Suresh Muthukumaraswamy
Associate Professor of Pharmacy at the University of Auckland
Data updated
Research Footprint
Suresh Muthukumaraswamy appears in 37 tracked papers (2013–2026), most studied alongside LSD, Ketamine and Psilocybin, across Healthy Volunteers, Neuroimaging & Brain Measures and Depressive Disorders.
Most-cited paper: Neural correlates of the LSD experience revealed by multimodal neuroimaging (875 citations).
Frequent co-authors: Robin Carhart-Harris, Rebecca Sumner and David Nutt.
Background & Research
Suresh Muthukumaraswamy is a neuro-psycho-pharmacologist specializing in how drugs modify brain activity. Using MEG, EEG, and fMRI, he has led pioneering work on the neural correlates of LSD, psilocybin, and ketamine. His current research at the University of Auckland investigates the effects of psychedelic microdosing on mood and neural plasticity in both healthy and clinical populations.
Key Impact
Expert in neuroimaging who produced the first images of the brain on LSD.
Collaboration Network
62 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Suresh Muthukumaraswamy is associated with.
University of Auckland
The University of Auckland hosts academic psychedelic research activity, including work led by Professor Suresh Muthukumaraswamy on LSD microdosing and related mental health applications.
View stakeholder →University of Wisconsin–Madison School of Pharmacy
The University of Wisconsin–Madison School of Pharmacy is the pharmacy school of the public research university UW–Madison, located in Madison, Wisconsin. It offers professional (PharmD), graduate and research programs in pharmaceutical sciences, clinical pharmacy, and related fields.
View stakeholder →